orthopaedics

Osteoporosis is the most common metabolic bone disease there is. Osteoporosis fractures produce significant health issues and the health system receives an enormous economic burden from them. Bone mineral density (BMD) testing remains the cornerstone for osteoporosis evaluation. BMD has an excellent correlation with fracture risks and permits medical providers to not only decide if medication is appropriate but also decide how well the individual is responding to the treatment.

Osteoporosis represents a global health issue. Over the age of fifty, one in two women and one in every five men has an osteoporotic fracture during his or her lifetime. Deaths relating to the aftereffects of osteoporotic fractures outnumber all deaths from cancer cases of uterus, cervix, and ovaries combine.